Angiogenic cell therapy for severe ischemic diseases

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 2, 2013, Pages 176-181

  Yamaguchi, Teruhide ^a   Kanayasu Toyoda, Toshie ^a   Uchida, Eriko ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

AC133; Angiogenesis; CD34; Cell therapy; Endothelial progenitor cell

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN;

ANGIOGENESIS; ANKLE BRACHIAL INDEX; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD34 SELECTION; CELL TYPE; CLINICAL EFFECTIVENESS; EARLY ENDOTHELIAL PROGENITOR CELL; ENDOTHELIAL PROGENITOR CELL; HEART CONTRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; IN VITRO STUDY; ISCHEMIA; LATE ENDOTHELIAL PROGENITOR CELL; LIMB ISCHEMIA; MONONUCLEAR CELL; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN ASSESSMENT; PATIENT SAFETY; REGENERATIVE MEDICINE; SKIN TEMPERATURE; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION;

EID: 84874080009     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-01008     Document Type: Article

References (34)

1. Asahara T, Murohara T, Sullivan A., Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964-967 (1997).
2. Shi Q, Rafii S, Wu M.H., Wijelath ES, Yu C, Ishida A, Fujita Y., Kothari S, Mohle R, Sauvage L.R., Moore MA, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood, 92, 362-367 (1998).
3. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ. res., 110, 624-637 (2012).
4. Matoba S, Tatsumi T, Murohara T., Imaizumi T, Katsuda Y, Ito M., Saito Y, Uemura S, Suzuki H., Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H, TACT Follow-up Study Investigators. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am. Heart J., 156, 1010-1018 (2008).
5. Tateishi-Yuyama E., Matsubara H, Murohara T., Ikeda U, Shintani S, Masaki H., Amano K, Kishimoto Y, Yoshimoto K., Akashi H, Shimada K, Iwasaka T, Imaizumi T, Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet, 360, 427-435 (2002).
6. Onodera R, Teramukai S, Tanaka S., Kojima S, Horie T, Matoba S., Murohara T, Matsubara H, Fukushima M., BMMNC Follow-Up Study Investigators M-PBMNC Follow-Up Study Investigators. Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASo: pooled analysis for long-term prognosis. Bone Marrow Transplant., 46, 278-284 (2011).
7. Huang PP, Yang XF, Li S.Z., Wen JC, Zhang Y, Han ZC Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb. Haemost., 98, 1335-1342 (2007).
8. Horie T, Onodera R, Akamastu M., Ichikawa Y, Hoshino J, Kaneko E., Iwashita C, Ishida A, Tsukamoto T., Teramukai S, Fukushima M, Kawamura A, Japan Study Group of Peripheral Vascular Regeneration Cell Therapy (JPRCT). Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells. Atherosclerosis, 208, 461-466 (2010).
9. Dimmeler S, Burchfield J, Zeiher AM Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 28, 208-216 (2008).
10. Shintani S, Murohara T, Ikeda H., Ueno T, Honma T, Katoh A., Sasaki K, Shimada T, Oike Y., Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103, 2776-2779 (2001).
11. Kocher AA, Schuster MD, Szabolcs M.J., Takuma S., Burkhoff D, Wang J, Homma S., Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med., 7, 430-436 (2001).
12. Schatteman GC, Hanlon HD, Jiao C, Dodds S.G., Christy BA Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest., 106, 571-578 (2000).
13. + and CD34-mononuclear cells. Thromb. Haemost., 95, 301-311 (2006).
14. Yoon YS, Park JS, Tkebuchava T, Luedeman C., Losordo DW Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation, 109, 315 4-3157 (2004).
15. Rosenzweig A. Cardiac cell therapy - mixed results from mixed cells. N. Engl. J. Med., 355, 1274-1277 (2006).
16. Kawamoto A, Iwasaki H, Kusano K., Murayama T, Oyamada A, Silver M., Hulbert C, Gavin M, Hanley A., Ma H, Kearney M, Zak V, Asahara T, Losordo DW. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation, 114, 2163-2169 (2006).
17. + cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur. Heart J., 30, 1313-1321 (2009).
18. Mackie AR, Losordo DW CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex. Heart Inst. J., 38, 474-485 (2011).
19. Jiang M, He B, Zhang Q., Ge H, Zang MH, Han Z.H., Liu JP, Li JH, Zhang Q, Li H.B., Jin Y., He Q, Gong XR, Yin XY. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert opin. Biol. Ther., 10, 667-680 (2010).
20. + cells into early endothelial progenitor cells reveals highly differential gene expression. PLoS oNE, 6, e23210 (2011).
21. Dimmeler S. Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler. Thromb. Vasc. Biol., 30, 1088-1093 (2010).
22. Hirschi KK, Ingram DA, Yoder MC Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol., 28, 1584-1595 (2008).
23. Hristov M, Erl W, Weber PC Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol., 23, 1185-1189 (2003).
24. Jujo K, Ii M, Losordo DW Endothelial progenitor cells in neovas-cularization of infarcted myocardium. J. Mol. Cell. Cardiol., 45, 530-544 (2008).
25. Rehman J, Li J, Orschell C.M., March KL Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107, 1164-1169 (2003).
26. Wijelath ES, Rahman S, Murray J., Patel Y, Savidge G, Sobel M. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J. Vasc. Surg., 39, 655-660 (2004).
27. Kanayasu-Toyoda T., Yamaguchi T, Oshizawa T., hayakawa T. CD31 (PECAM-1)-bright cells derived from AC133-positive cells in human peripheral blood as endothelial-precursor cells. J. Cell. Physiol., 195, 119-129 (2003).
28. Bompais H, Chagraoui J, Canron X., Crisan M, Liu XH, Anjo A, Tolla-Le Port C, Leboeuf M, Charbord P, Bikfalvi A, Uzan G. human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood, 103, 2577-2584 (2004).
29. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest., 105, 71-77 (2000).
30. Yoder MC, Mead LE, Prater D, Krier T.R., Mroueh KN, Li F, Krasich R, Temm C.J., Prchal JT, Ingram DA Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109, 1801-1809 (2007).
31. Yoon CH, Hur J, Park K.W., Kim JH, Lee CS, Oh IY, Kim T.Y., Cho HJ, Kang HJ, Chae IH, Yang H.K., Oh BH, Park YB, Kim HS. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation, 112, 1618-1627 (2005).
32. Kanayasu-Toyoda T., Ishii-Watabe A, Suzuki T., Oshizawa T, Yamaguchi T. A new role of thrombopoietin enhancing ex vivo expansion of endothelial precursor cells derived from AC133-positive cells. J. Biol. Chem., 282, 33507-33514 (2007).
33. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. res., 95, 343-353 (2004).
34. + hematopoietic precursors. Arterioscler. Thromb. Vasc. Biol., 27, 1572-1579 (2007).